Renub

    United States Specialty Pharmaceuticals Market & Forecast by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, AMD, HGH, Others), Companies

    Excel: 4 Hours
    PDF: 4 Hours
    Jan 2020
    Pages: 155

    Get Free Customization in this Report

    In the United States, the Pharmaceutical market can be categories into two types of drugs Traditional as well as Specialty drugs. In recent times, Specialty drugs have gained a substantial foothold in the US market, and as estimated, it tends to gain more momentum in the upcoming years. For this, the credit goes to the companies initiatives towards Research and Developments (R&D’s) of these drugs. As per Renub Research Analysis, it is expected that United States Specialty Pharmaceutical Market will be US$ 387 Billion by 2026.

     


    During the years, Specialty pharmaceutical has changed much due to speciality drugs being in the final stages of development in the United States. Speciality drugs are for rare and chronic diseases, and the drugs fall under this category are much expensive compared to traditional medications. Research has shown that a large portion of the US population was ageing and more people are prone towards chronic and rare diseases like cancer, Autoimmune, Multiple sclerosis.


    In the year 2018, the FDA has approved 21 new molecular entities. Out of these products, 12 are regarded as speciality pharmaceutical based on variables such as indication and designed use population, administrative and tracking considerations, price and restricted delivery procedures. Dating back five years, spending on speciality drugs has almost doubled in the United States.


    An ageing population, rise in the net per capita medicine spending on speciality drugs, improving life expectancy rate, the prevalence of chronic diseases are likely to boost the United States Specialty pharmaceuticals market at a staggering rate in upcoming years.


    Renub Research report titled “United States Specialty Pharmaceuticals Market, by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, Age-related macular degeneration (AMD), Human Growth Hormones (HGH) Others), Company ( CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Analysis” provides a complete analysis of United States Specialty Pharmaceutical Market.


    All the 9 Diseases have been studied from two points

    •    Market
    •    Drugs Pipeline


    Application - The Report Covers the Market, Drugs Pipelines of 9 diseases

    1.    Oncology
    2.    Autoimmune
    3.    Immunology
    4.    HIV
    5.    Multiple Sclerosis
    6.    Hematology
    7.    Age-related macular degeneration (AMD)
    8.    Human Growth Hormones (HGH)
    9.    Others

     


    All the Key players have been covered from 3 Viewpoints

    •    Overview
    •    Recent Developments
    •    Revenue Analysis


    Company Analysis

    •    CVS Health
    •    Endo International
    •    UnitedHealth Group Incorporated
    •    Recordati Pharmaceuticals

     

    If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com

    1.    Introduction

    2.    Research & Methodology
    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges
    4.3    Trend and Opportunities


    5.    Market Analysis - United States Specialty Pharmaceuticals

    5.1    Market
    5.2    Specialty Drug Pipeline


    6.    Share Analysis

    6.1    Applications
    6.2    Segments

    6.2.1    Traditional
    6.2.2    Specialty


    7.    By Applications

    7.1    Oncology

    7.1.1    Market
    7.1.2    Pipelines

    7.2    Autoimmune

    7.2.1    Market
    7.2.2    Pipelines

    7.3    HIV

    7.3.1    Market
    7.3.2    Pipelines

    7.4    Immunology

    7.4.1    Market
    7.4.2    Pipelines

    7.5    Multiple Sclerosis (MS)

    7.5.1    Market
    7.5.2    Pipelines

    7.6    Hematology

    7.6.1    Market

    7.7    Age-related macular degeneration (AMD)

    7.7.1    Market
    7.7.2    Pipelines

    7.8    Human Growth Hormones (HGH)

    7.8.1    Market
    7.8.2    Pipelines

    7.9    Others


    8.    Key Players Analysis

    8.1    CVS Health

    8.1.1    Overview
    8.1.2    Recent Developments
    8.1.3    Revenues

    8.2    Endo International

    8.2.1    Overview
    8.2.2    Recent Developments
    8.2.3    Revenues

    8.3    UnitedHealth Group Incorporated

    8.3.1    Overview
    8.3.2    Recent Developments
    8.3.3    Revenues

    8.4    Recordati Pharmaceuticals

    8.4.1    Overview
    8.4.2    Recent Developments
    8.4.3    Revenues

     

     

     

    List of Figures:

    Figure-01:        Excess Revenues Earned Through Premium Pricing Of Products In The US As A Percentage Of The Company’s Global Research And Development Expenditures, 2015
    Figure-02:        United States – Specialty Pharmaceuticals Market, (Billion US$), 2015 – 2020
    Figure-03:        United States – Forecast For Specialty Pharmaceuticals Market, (Billion US$), 2021 – 2026
    Figure-04:        United States – Market Share By Traditional vs Specialty, (Percent), 2015 – 2020
    Figure-05:        United States – Forecast for Market Share By Traditional vs Specialty, (Percent), 2021 – 2026
    Figure-06:        By Application – Oncology Specialty Pharmaceuticals Market, (Billion US$), 2015 – 2020
    Figure-07:        By Application – Forecast for Oncology Specialty Pharmaceuticals Market, (Billion US$), 2021 – 2026
    Figure-08:        By Application – Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2015 – 2020
    Figure-09:        By Application – Forecast for Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2021 – 2026
    Figure-10:        By Application – HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
    Figure-11:        By Application – Forecast for HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 – 2020
    Figure-12:        By Application – Immunology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
    Figure-13:        By Application – Forecast for Immunology Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-14:        By Application – Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
    Figure-15:        By Application – Forecast for Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-16:        By Application – Hematology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
    Figure-17:        By Application – Forecast for Hematology Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-18:        By Application – Age Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
    Figure-19:        By Application – Forecast for Age Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-20:        By Application – Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
    Figure-21:        By Application – Forecast for Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-22:        By Application – Others Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-23:        By Application – Forecast for Others Specialty Pharmaceutical Market (Billion US$), 2021 – 2026
    Figure-24:        Forecast For CVS Health Revenue Market (Million US$), 2021 – 2026
    Figure-25:        Global – Endo International Specialty Products Revenue (Million US$), 2015 – 2020
    Figure-26:        Global – Forecast For Endo International Specialty ProductsRevenue (Million US$), 2021 – 2026
    Figure-27:        Global – UnitedHealth Group Incorporated Revenue (Million US$), 2015 – 2020
    Figure-28:        Global – Forecast For United Health Group Incorporated Revenue (Million US$), 2021 – 2026
    Figure-29:        Global – Recordati Pharmaceuticals Ltd Revenue (Million US$), 2015 – 2020
    Figure-30:        Global – Forecast For Recordati Pharmaceuticals Ltd Revenue (Million US$), 2021 – 2026

     

    List of Tables:

    Table-01:        Specialty New Product Approvals in the Past Twelve Months
    Table-02:        United States – Market Share By Applications, (Percent), 2015 – 2020
    Table-03:        United States – Forecast for Market Share By Applications, (Percent), 2021 – 2026
    Table-04:        United States – Oncology Specialty Drug/R&D Pipeline
    Table-05:        Drugs Pipelines – 2020
    Table-06:        Specialty Drugs Pipeline – 2020

    Related Reports